• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对研究的信赖。

- faith in the embrace of research.

机构信息

Department of Kaumarabhritya, Shri NPA Govt Ayurved College, Raipur, CG, India.

出版信息

J Complement Integr Med. 2021 Nov 11;19(2):161-172. doi: 10.1515/jcim-2021-0394. eCollection 2022 Jun 1.

DOI:10.1515/jcim-2021-0394
PMID:34766744
Abstract

Childhood needs diverse nutritional requirements. Poor appetite, lifestyle changes, and poor digestion affects child immunity and make them prone to diseases. , a branch of Ayurveda which deals in child and adolescent health care, has a unique concept of (SP) to promote generalized immunity and intellect. is commonly recommended to children between 0 and 12 years of age and given as a general health promoter to improve intellect, digestion, strength, immunity, longevity, and complexion. Multiple benefits of are mentioned in different Samhitas which needs to be explored on scientific background. Authors have highlighted content variabilities, plausible mechanisms, research tasks and potentials, lacunae, and future prospects about This manuscript is a spotlight on current social, clinical, marketing, and scientific information of can be a cost-effective, safe, infrastructure compatible, and prevention-centric approach to improve children's overall health status and has the potential to serve as a positive health care program for children.

摘要

儿童有多样化的营养需求。食欲不振、生活方式改变和消化不良会影响儿童的免疫力,使他们容易患病。阿育吠陀医学是一门专门研究儿童和青少年保健的医学分支,它有一个独特的概念,即使用特定的植物药(SP)来促进整体免疫力和智力。该植物药通常推荐给 0 至 12 岁的儿童使用,作为一种一般的健康促进剂,以提高智力、消化、力量、免疫力、长寿和肤色。不同的《萨希塔》中提到了该植物药的多种益处,需要在科学背景下进行探索。作者强调了该植物药的内容可变性、可能的机制、研究任务和潜力、空白以及未来前景。本文聚焦于该植物药的当前社会、临床、营销和科学信息,它可能是一种具有成本效益、安全、与基础设施兼容且以预防为中心的方法,可以改善儿童的整体健康状况,并有可能成为儿童的积极保健计划。

相似文献

1
- faith in the embrace of research.对研究的信赖。
J Complement Integr Med. 2021 Nov 11;19(2):161-172. doi: 10.1515/jcim-2021-0394. eCollection 2022 Jun 1.
2
Swarna Bindu Prashana-an Ancient Approach to Improve the Infant's Immunity.苏瓦尔纳宾度普拉沙那——一种提高婴儿免疫力的古老方法。
Biol Trace Elem Res. 2021 Jun;199(6):2145-2148. doi: 10.1007/s12011-020-02353-y. Epub 2020 Aug 27.
3
Immunomodulatory activity of (oral administration of gold as electuary) in infants - A randomized controlled clinical trial.(口服金制剂糖剂)对婴儿的免疫调节活性——一项随机对照临床试验
Ayu. 2019 Oct-Dec;40(4):230-236. doi: 10.4103/ayu.AYU_33_19. Epub 2021 Jan 14.
4
A critical appraisal on Swarnaprashana in children.对儿童酥油滋补剂的批判性评价。
Ayu. 2014 Oct-Dec;35(4):361-5. doi: 10.4103/0974-8520.158978.
5
Blood compatibility studies of Swarna bhasma (gold bhasma), an Ayurvedic drug.阿育吠陀药物斯瓦纳·巴斯马(金巴斯马)的血液相容性研究。
Int J Ayurveda Res. 2011 Jan;2(1):14-22. doi: 10.4103/0974-7788.83183.
6
Ayurvedic bhasma: nanomedicine of ancient India--its global contemporary perspective.阿育吠陀灰:古印度的纳米医学——其全球当代视角。
J Biomed Nanotechnol. 2011 Feb;7(1):68-9. doi: 10.1166/jbn.2011.1205.
7
Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.印度阿育吠陀药用植物用于治疗神经退行性疾病的科学依据:南非醉茄。
Cent Nerv Syst Agents Med Chem. 2010 Sep 1;10(3):238-46. doi: 10.2174/1871524911006030238.
8
Development of Ayurveda - Tradition to trend.阿育吠陀的发展——传统到潮流。
J Ethnopharmacol. 2017 Feb 2;197:10-24. doi: 10.1016/j.jep.2016.09.024. Epub 2016 Sep 12.
9
Characterization of Swarna Bhasma and Swarnaprash and Determination of Antimicrobial Properties Against Gut-Pathobiont and Symbiont.金色煅灰和金色糖浆的特性表征以及对肠道致病共生菌和共生菌的抗菌特性测定
Biol Trace Elem Res. 2025 May;203(5):2924-2932. doi: 10.1007/s12011-024-04353-8. Epub 2024 Sep 6.
10
Enhanced Internalization of Indian Ayurvedic Swarna Bhasma (Gold Nanopowder) for Effective Interaction with Human Cells.增强印度阿育吠陀金粉(纳米金粉)的内化作用以实现与人类细胞的有效相互作用。
J Nanosci Nanotechnol. 2018 Oct 1;18(10):6791-6798. doi: 10.1166/jnn.2018.15503.